Methods for the Study of Long Noncoding RNA in Cancer Cell Signaling

Methods Mol Biol. 2021:2174:89-118. doi: 10.1007/978-1-0716-0759-6_7.

Abstract

With the advances in sequencing technology and transcriptome analysis, it is estimated that up to 75% of the human genome is transcribed into RNAs. This finding prompted intensive investigations on the biological functions of noncoding RNAs and led to very exciting discoveries of microRNAs as important players in disease pathogenesis and therapeutic applications. Research on long noncoding RNAs (lncRNAs) is in its infancy, yet a broad spectrum of biological regulations has been attributed to lncRNAs. Here, we provide a collection of detailed experimental protocols for lncRNA studies, including lncRNA immunoprecipitation, lncRNA pull-down, lncRNA northern blot analysis, lncRNA in situ hybridization, and lncRNA knockdown. We hope that the information included in this chapter can speed up research on lncRNAs biology and eventually lead to the development of clinical applications with lncRNA as novel prognostic markers and therapeutic targets.

Keywords: In situ hybridization; Long noncoding RNA; Northern blots; RNA immunoprecipitation; RNA pull-down; Short hairpin RNA.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Blotting, Northern / methods
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Genes, Tumor Suppressor
  • Genome, Human
  • Humans
  • Immunoprecipitation / methods
  • In Situ Hybridization / methods
  • Molecular Biology / methods*
  • Neoplasms / genetics*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Oncogenes
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism
  • Signal Transduction

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding